Beta-lactamase resistance genes in Enterobacteriaceae from Nigeria
African Journal of Laboratory Medicine
| Field | Value | |
| Title | Beta-lactamase resistance genes in Enterobacteriaceae from Nigeria | |
| Creator | Awosile, Babafela B. Agbaje, Michael Adebowale, Oluwawemimo Kehinde, Olugbenga Omoshaba, Ezekiel | |
| Description | Background: Beta-lactamase genes are one of the most important groups of antimicrobial resistance genes in human and animal health. Therefore, continuous surveillance of this group of resistance genes is needed for a better understanding of the local epidemiology within a country and global dissemination.Aim: This review was carried out to identify different beta-lactamase resistance genes reported in published literature from Nigeria.Methods: Systematic review and meta-analysis was carried out on eligible Nigerian articles retrieved from electronic literature searches of PubMed®, African Journals Online, and Google Scholar published between January 1990 and December 2019. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses method was adopted to facilitate clarity and transparency in reporting review findings.Results: Fifty-seven articles were included. All beta-lactamases reported were detected from Gram-negative bacteria, particularly from Enterobacteriaceae. Thirty-six different beta-lactamase genes were reported in Nigeria. These genes belong to the narrow-spectrum, AmpC, extended-spectrum and carbapenemase beta-lactamase resistance genes. The pooled proportion estimate of extended-spectrum beta-lactamase genes in Nigeria was 31% (95% confidence interval [CI]: 26% – 36%, p 0.0001), while the estimate of the blaCTX-M-15 gene in Nigeria was 46% (95% CI: 36% – 57%, p 0.0001). The proportion estimate of AmpC genes was 32% (95% CI: 11% – 52%, p 0.001), while the estimate for carbapenemases was 8% (95% CI: 5% – 12%, p 0.001).Conclusion: This study provides information on beta-lactamase distribution in Nigeria. This is necessary for a better understanding of molecular epidemiology of clinically important beta-lactamases, especially the extended-spectrum beta-lactamases and carbapenemases in Nigeria. | |
| Publisher | AOSIS | |
| Date | 2022-02-22 | |
| Identifier | 10.4102/ajlm.v11i1.1371 | |
| Source | African Journal of Laboratory Medicine; Vol 11, No 1 (2022); 10 pages 2225-2010 2225-2002 | |
| Language | eng | |
| Relation |
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:
https://ajlmonline.org/index.php/ajlm/article/view/1371/2132
https://ajlmonline.org/index.php/ajlm/article/view/1371/2133
https://ajlmonline.org/index.php/ajlm/article/view/1371/2134
https://ajlmonline.org/index.php/ajlm/article/view/1371/2135
|
|
ADVERTISEMENT
